Stay updated with breaking news from Timothys Ernst. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FORA Capital LLC raised its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) by 34.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,569 shares of the medical research company’s stock after buying an additional 400 shares during […]
Russell Investments Group Ltd. cut its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) by 11.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 60,365 shares of the medical research company’s stock after selling 7,564 shares during the period. Russell Investments Group […]
Toronto Dominion Bank increased its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) by 18.1% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 11,917 shares of the medical research company’s stock after purchasing an additional 1,830 shares during the period. […]
Metis Global Partners LLC lifted its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) by 33.3% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 664 shares of the medical research company’s stock after buying an additional 166 shares during the quarter. […]
Bio-Rad Laboratories (NYSE:BIO – Get Rating) issued its earnings results on Thursday. The medical research company reported $3.34 earnings per share for the quarter, topping the consensus estimate of $3.24 by $0.10, Briefing.com reports. Bio-Rad Laboratories had a positive return on equity of 4.19% and a negative net margin of 7.01%. The business had revenue […]